Elanco Animal Health Inc (ELAN)
14.02
-0.17
(-1.20%)
USD |
NYSE |
Nov 14, 13:41
Elanco Animal Health Enterprise Value: 10.88B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 10.88B |
| November 12, 2024 | 10.85B |
| November 11, 2024 | 10.92B |
| November 08, 2024 | 10.82B |
| November 07, 2024 | 11.04B |
| November 06, 2024 | 10.22B |
| November 05, 2024 | 10.13B |
| November 04, 2024 | 10.08B |
| November 01, 2024 | 10.10B |
| October 31, 2024 | 10.12B |
| October 30, 2024 | 10.18B |
| October 29, 2024 | 10.05B |
| October 28, 2024 | 10.05B |
| October 25, 2024 | 10.00B |
| October 24, 2024 | 9.992B |
| October 23, 2024 | 10.05B |
| October 22, 2024 | 10.13B |
| October 21, 2024 | 10.11B |
| October 18, 2024 | 10.28B |
| October 17, 2024 | 10.21B |
| October 16, 2024 | 10.42B |
| October 15, 2024 | 10.76B |
| October 14, 2024 | 10.97B |
| October 11, 2024 | 10.97B |
| October 10, 2024 | 11.04B |
| Date | Value |
|---|---|
| October 09, 2024 | 11.08B |
| October 08, 2024 | 11.02B |
| October 07, 2024 | 11.06B |
| October 04, 2024 | 11.11B |
| October 03, 2024 | 11.03B |
| October 02, 2024 | 11.01B |
| October 01, 2024 | 11.03B |
| September 30, 2024 | 11.13B |
| September 27, 2024 | 12.34B |
| September 26, 2024 | 12.05B |
| September 25, 2024 | 12.01B |
| September 24, 2024 | 12.12B |
| September 23, 2024 | 12.40B |
| September 20, 2024 | 12.22B |
| September 19, 2024 | 12.71B |
| September 18, 2024 | 12.50B |
| September 17, 2024 | 12.32B |
| September 16, 2024 | 12.44B |
| September 13, 2024 | 12.41B |
| September 12, 2024 | 12.37B |
| September 11, 2024 | 12.42B |
| September 10, 2024 | 12.44B |
| September 09, 2024 | 12.57B |
| September 06, 2024 | 12.72B |
| September 05, 2024 | 12.85B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
8.410B
Minimum
May 21 2020
22.89B
Maximum
Aug 03 2021
14.61B
Average
12.96B
Median
Apr 09 2024
Enterprise Value Benchmarks
| Baxter International Inc | 27.52B |
| Edwards Lifesciences Corp | 35.45B |
| Syros Pharmaceuticals Inc | -7.537M |
| Opus Genetics Inc | -12.86M |
| Edgewise Therapeutics Inc | 2.607B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 364.00M |
| Revenue (Quarterly) | 1.03B |
| Total Expenses (Quarterly) | 1.035B |
| EPS Diluted (Quarterly) | 0.73 |
| Gross Profit Margin (Quarterly) | 52.23% |
| Profit Margin (Quarterly) | 35.34% |
| Earnings Yield | 2.85% |
| Operating Earnings Yield | 3.64% |
| Normalized Earnings Yield | -1.122 |